Navigation Links
OrthoAccel Technologies, Inc. Selected to Pitch at the 2010 WBTshowcase
Date:3/16/2010

ARLINGTON, Texas, March 16 /PRNewswire/ -- OrthoAccel Technologies, Inc. is among the over 100 companies and technology innovators from across the nation and around the world that will compete for top honors at the WBT2010, March 16-17 in Arlington-DFW, Texas.

(Logo: http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO)

OrthoAccel's AcceleDent System, an acceleration device to enhance orthodontics, will be rigorously prepped by WBTshowcase commercialization experts to present to participants including venture capitalists and Fortune 1000 licensees. Over 500 professionals attended last year's event.

"The conventional wisdom for venture capital is that a down economy can be a great time to invest," said Paul Huleatt, WBTshowcase CEO. "The pace of new innovations accelerates, the best deals rise quickly to the top and sophisticated investors receive great value for their money."

According to Mr. Huleatt, one in three WBTshowcase presenters goes on to secure venture funding, license their technology, or sell their IP outright, representing over $450 million raised to date.

Michael Lowe, CEO of OrthoAccel, commented, "We are committed to building the AcceleDent brand around the customer above all else." Michael Kaufman, VP Business Development and Marketing for OrthoAccel remarked, "Introducing a new product category will come with many challenges; launching innovation always does. An exciting benefit of AcceleDent is that it can be used to enhance orthodontic treatment of any approach, regardless of the type of appliance or profile of patient."

Mr. Huleatt highlighted that the companies groomed to present at the WBTshowcase leave with new knowledge and contacts to take their technologies to the market and beyond.

OrthoAccel is nearing conclusion of another US clinical trial at the UT Health Science Center in San Antonio with an anticipated completion date during the first half of 2010.

About OrthoAccel Technologies, Inc.

Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.  

About the AcceleDent System

AcceleDent represents the first clinical approach to safely accelerate orthodontic tooth movement via modulating biology. The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling. Importantly, the device works complementary with all existing orthodontic technologies. AcceleDent is neither FDA cleared nor FDA approved; it is currently investigational only in the United States.  More information can be found at www.acceledent.com or requested via info@orthoaccel.com

About WBTshowcase

The WBTshowcase is the nation's premier event showcasing the largest collection of undiscovered technologies emanating from the world's leading universities, labs and research institutions. The 2010 WBTshowcase will be held March 16-17 in Arlington-DFW, Texas. www.wbtshowcase.com

Media Contact Michael K. Lowe, CEO +1 (281) 798-5318

SOURCE OrthoAccel Technologies, Inc.

Back to top

RELATED LINKS
http://www.acceledent.com

'/>"/>

SOURCE OrthoAccel Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
2. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
3. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
4. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
5. Neurobiological Technologies, Inc. Reports Receipt of Notice From Nasdaq
6. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
7. Neurobiological Technologies, Inc. Reports Fourth Quarter and Fiscal Year-End Financial Results for 2007 Announces 1-for-7 Reverse Stock Split
8. Neurobiological Technologies, Inc. (Nasdaq: NTIID)
9. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
10. Maven Biotechnologies, LLC to Present at BIOCOM Investor Conference
11. Orchid Cellmark to Purchase ReliaGene Technologies, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... , ... June 23, 2017 ... ... launch of a redesigned, easier-to-navigate website for all six of their healthcare ... physicians, nurses, dentists, pharmacists, physical and occupational therapists, and biotechnicians, DocCafe.com and ...
(Date:6/22/2017)... Colorado (PRWEB) , ... June 21, 2017 , ... ... RTP regional office in North Carolina, and engages Timothy Reinhardt to manage the ... of quality leadership at Pfizer Inc, with his most recent role as the ...
(Date:6/22/2017)... ... June 22, 2017 , ... Ovation ... infertility as a disease, bringing new hope for prospective parents who are challenged ... meeting to back the World Health Organization’s designation in hopes of changing the ...
(Date:6/22/2017)... ... , ... The first human cell line HeLa, established in 1951, has entered ... of human cell lines with HeLa cells were published. Until recently, cross-contamination and misidentification ... is associated with dramatic consequences for research. , In this educational webinar, which ...
Breaking Biology Technology:
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University (PolyU) ... ground breaking 3D fingerprint minutiae recovery and matching technology, pushing contactless ... use in identification, crime investigation, immigration control, security of access and ... ... A research team led by Dr Ajay Kumar ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):